micro News and Research

RSS

Santica Research Labs launches CelluScience Anti-Cellulite Beaute Intensive dietary supplement

More than 85% of women in the U.S. have cellulite. Now, there is a revolutionary new anti-cellulite dietary supplement clinically proven to help target the thighs, hips and gluteal area.

28 Jan 2010

Update on Cardium Therapeutics' plans for commercial development of Generx

Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.

27 Jan 2010

New technology may allow scientists to monitor real time activity of protein network

A new assay capable of examining hundreds of proteins at once and enabling new experiments that could dramatically change our understanding of cancer and other diseases has been invented by a team of University of Chicago scientists.

24 Jan 2010

The American Journal of Pathology: Highlights from February 2010 issue

A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.

22 Jan 2010

Plan launches international appeal to support its emergency operations in Haiti’s affected areas

Aid workers from children's charity Plan International are in a race to help survivors of the devastating Haiti earthquake cope with the aftermath.

18 Jan 2010

This year's Aegean Cornea Conference to celebrate 20th Anniversary of LASIK Surgery

The Institute of Vision and Optics at the University of Crete announced today that this year’s Aegean Cornea Conference will celebrate the 20th Anniversary of LASIK surgery. The biennial event will feature world leaders in cornea, cataract and refractive surgery as well as presentations on medical and scientific breakthroughs in the field.

18 Jan 2010

Agilent Technologies launches two Greenhouse Gases Analyzers

Agilent Technologies Inc., today announced the availability of two Greenhouse Gases (GHG) Analyzers for simultaneous analysis of methane (CH4), carbon dioxide (CO2), and nitrous oxide (N2O) in air samples. The analyzers also can be used for soil gas analysis or plant breathing studies, where the samples contain CH4, N2O, and CO2. Both analyzers easily can be expanded to determine sulfur hexafluoride (SF6).

13 Jan 2010

ERA-NET PathoGenoMics announces third international joint call for infectious disease research

ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.

13 Jan 2010

Self-employment tax changes for 2009

Prior to preparing 2009 tax forms, the self-employed and micro-businesses (fewer than 10 employees) should be aware of a few tax law changes, including changes in the standard mileage rate and the self-employment tax.

13 Jan 2010

Extended treatment with active ingredient increases bone volume and calcium content

Genta Incorporated today announced publication of two scientific studies that test the active ingredient in Genta’s program to develop orally available gallium-containing compounds and the Company’s marketed product, Ganite® (gallium nitrate for injection).

13 Jan 2010

Pall acquires U.S. biotechnology company

Pall Corporation, a global leader in filtration, separation and purification, today announced its acquisition of MicroReactor Technologies, Inc. (MRT), a privately held U.S. biotechnology company. MRT has developed a reliable, easy-to-use and cost-effective miniature bioreactor technology platform.

From Pall Corporation 12 Jan 2010

Stem cell therapy holds promise as potential alternative to bone grafting operations

A study published this week reinforces the potential value of stem cells in repairing major injuries involving the loss of bone structure.

12 Jan 2010

New therapeutic treatment may provide a potential alternative to bone grafting operation

A study published this week reinforces the potential value of stem cells in repairing major injuries involving the loss of bone structure.

12 Jan 2010

A.P. Pharma receives final milestone payment of $2.5M from Paul Capital Healthcare

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.

11 Jan 2010

Tampa Bay Partnership releases new briefs on the economic and business growth in the Tampa Bay Region

SRI International Dedicates New Tampa Bay Research Facility SRI International, one of the world's leading independent research and technology development organizations, officially opened its new 40,000-square-foot research facility located at the Port of St. Petersburg.

11 Jan 2010

New technique offers a low-cost alternative to make 'micromotors' for surgical instruments

Researchers at Purdue University have created a magnetic "ferropaper" that might be used to make low-cost "micromotors" for surgical instruments, tiny tweezers to study cells and miniature speakers.

6 Jan 2010

Findings open up significant possibilities for developing micro-screening devices for drug discovery

A Nobel-winning process for testing new drugs to treat diseases such as Huntington's, Parkinson's, and muscular dystrophy is getting an electrical charge.

6 Jan 2010

WPI researchers lay groundwork for new generation of advanced prosthetic limbs

The conflicts in Iraq and Afghanistan have left a terrible legacy: more than 1,200 returning American soldiers have lost one or more limbs. To address this growing national need, researchers at Worcester Polytechnic Institute (WPI) are laying the groundwork for a new generation of advanced prosthetic limbs that will be fully integrated with the body and nervous system.

5 Jan 2010

Comprehensive studies on nanotechnology's HSE aspects vital

The advent of nanotechnology on the modern landscape has dramatically changed the shape, size, quality, cost, and efficiency of various applications. Nanotechnology is believed to be the most path-breaking technology, with this market expected to reach $1 trillion by 2015. The remarkable properties of the various nanomaterials have caught the attention of scientists, researchers, and manufacturers alike, and ongoing research activities are underway to harness their potential for the overall betterment of society.

5 Jan 2010

Carbon nanotube: A viable alternative for rapid DNA sequencing

Faster sequencing of DNA holds enormous potential for biology and medicine, particularly for personalized diagnosis and customized treatment based on each individual's genomic makeup.

4 Jan 2010

micro News and Research

Santica Research Labs launches CelluScience Anti-Cellulite Beaute Intensive dietary supplement

Update on Cardium Therapeutics' plans for commercial development of Generx

New technology may allow scientists to monitor real time activity of protein network

The American Journal of Pathology: Highlights from February 2010 issue

Plan launches international appeal to support its emergency operations in Haiti’s affected areas

This year's Aegean Cornea Conference to celebrate 20th Anniversary of LASIK Surgery

Agilent Technologies launches two Greenhouse Gases Analyzers

ERA-NET PathoGenoMics announces third international joint call for infectious disease research

Self-employment tax changes for 2009

Extended treatment with active ingredient increases bone volume and calcium content

Pall acquires U.S. biotechnology company

Stem cell therapy holds promise as potential alternative to bone grafting operations

New therapeutic treatment may provide a potential alternative to bone grafting operation

A.P. Pharma receives final milestone payment of $2.5M from Paul Capital Healthcare

Tampa Bay Partnership releases new briefs on the economic and business growth in the Tampa Bay Region

New technique offers a low-cost alternative to make 'micromotors' for surgical instruments

Findings open up significant possibilities for developing micro-screening devices for drug discovery

WPI researchers lay groundwork for new generation of advanced prosthetic limbs

Comprehensive studies on nanotechnology's HSE aspects vital

Carbon nanotube: A viable alternative for rapid DNA sequencing

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News